Leadership

Lindsay Rosenwald

Chairman, President, CEO, Fortress Biotech

Dr. Rosenwald has served as Chairman, President & CEO of Fortress Biotech since December 2013 and has served as a member of the Fortress Board of Directors since October 2009. Since 2009, Dr. Rosenwald has served as Co-Portfolio Manager and Partner of Opus Point Partners, LLC (‘Opus’), an asset management firm in the life sciences industry. Prior to that, from 1991 to 2008, he served as the Chairman of Paramount BioCapital, Inc. Over the last 23 years, Dr. Rosenwald has acted as a biotechnology entrepreneur and been instrumental in the founding and recapitalization of numerous public and private biotechnology and life sciences companies. Dr. Rosenwald received his B.S. in finance from Pennsylvania State University and his M.D. from Temple University School of Medicine.

Claude Maraoui

President & CEO, Journey Medical Corporation

Claude has more than 25 years of experience in commercializing some of the most successful dermatology products in the world. He served as Vice President of Dermatology Sales at Medicis Pharmaceutical Corporation and has held various leadership positions in marketing and sales for therapeutic and aesthetic dermatology. He has executed more than 50 product launches during his career. In 2012, Valeant Pharmaceuticals International Inc., acquired Medicis for approximately $2.6B. Claude received his B.S. in business and marketing from Rutgers University.

Robert Nevin

Executive VP of Sales

Robert has more than 20 years of experience in pharmaceutical, lab and medical management. In his new role, he will assume overall responsibility for sales, trade and managed care functions. Robert comes to Journey from The Dermatology Alliance where he served as Managing Partner for one of the nation’s largest independent physician associations in the specialty of dermatology. Robert received his B.S. in business administration and finance from Seton Hall University.

Andrew Zwible

Director of Operations, Journey Medical Corporation

Andrew has 5 years of experience in dermatology pharmaceuticals, working for Medicis and Valeant as a forecasting and analytics expert. At Medicis he assisted with the $455MM acquisition of Graceway Pharmaceuticals LLC and the sell-side $2.6B acquisition of Medicis. He has previous experience in investment banking and financial analysis. Andrew received his B.S. in biomedical/medical engineering from Johns Hopkins University, his M.S. in Health care administration/management from Arizona State University and his M.B.A. in finance from Arizona State University.

Ernest Galvan

Executive Director Marketing & Strategic Planning

Ernest has more than 26 years of experience in the dermatology pharmaceutical industry. With over 23 years in brand management and development, he has translated concepts into powerful marketing and brand solutions for a variety of dermatologic lines. Prior to Journey Medical, his experience includes Bristol Myers Squibb, Medicis, Ranbaxy, and Sun Dermatology. Ernest received his B.B.A. in marketing from Stephen F. Austin State University and his M.B.A. in marketing from La Salle University.